Nitric oxide-mediated signalization and nitrosative stress in neuropathology

Journal of Medical Biochemistry

Volumn 31, Issue 4, 2012, Pages 295-300

  Stojanović, Ivana ^a   Ljubisavljević, Srdan ^a   Stevanović, Ivana ^b   Pavlović, Radmila ^a   Cvetković, Tatjana ^a   Dordević, Vidosava B ^a   Pavlović, Dušica ^a   Vojinović, Slobodan ^a   Bašić, Jelena ^a  

^a UNIVERSITY OF NI   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

neurodegeneration; neuroinflammation; nitric oxide; nitrosative stress; protein S nitrosylation

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRITE; PARKIN; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ARTICLE; CELL DAMAGE; CHROMATIN; DOWN REGULATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALITIS; GENE EXPRESSION; HUMAN; MITOCHONDRIAL DNA DISORDER; MITOCHONDRIAL RESPIRATION; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NITROSATIVE STRESS; NITROSYLATION; NONHUMAN; PARKINSON DISEASE; PHAGOCYTOSIS; PROTEIN FOLDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 84876552471     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-012-0030-1     Document Type: Article

References (52)

1. Guix FX, Uribesaigo I, Coma M, Munoz FJ. The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol 2005; 76: 126-52
2. Patcher P, Beckman JS, Liaudet L. Nitric oxide and peroxy nitrite in health and disease. Physiol Rev 2007; 87: 315-24
3. Ibragić S, Sofić E, Suljić E, Avdagić N, Bajraktarević A, Tahirović I. Serum nitric oxide concentrations in patients with multiple sclerosis and patients with epilepsy. J Neural Transm 2011; 119(1): 7-11
4. Bagasra O, Michaels FH, Zheng YM, Bobroski LE, Spitsin SV, Fu ZF et al. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci USA 1995; 92(26): 12041-5
5. Cross AH, Keeling RM, Goorha S, San M, Rodi C, Wyatt PS, et al. Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. J Neuroimmunol 1996; 71(1-2): 145-53
6. Rejdak K, Petzold A, Stelmasiak Z, Giovanoni G. Cerebrospinal fluid proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis. Mult Scler 2008; 14(1): 59-66
7. Danilov AI, Andersson M, Bavand N, Wiklund NP, Olsson T, Brundin L. Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis. J Neuro immunol 2003; 136: 112-8
8. Bizzozero O, DeJesus G, Bixler HA, Pastuszyn A. Evidence of nitrosative damage in the brain white matter of patients with multiple sclerosis. Neurochem Res 2005; 30(1): 139-49
9. Encinas JM, Manganas L, Enikolopov G. Nitric oxide and multiple sclerosis. Curr Neurol Neurosci Rep 2005; 5(3): 232-8
10. Redford EJ, Kapoor R, Smith KJ. Nitric oxide donors reversibly block axonal conduction: Demyelinated axons are especially susceptible. Brain 1997; 120: 2149-57
11. Broillet MC. S-nitrosylation of proteins. Cell Mol Life 1996; 55: 1036-42
12. Roghani M, Mahboudi F, Saharian MA, Etemadifar M, Esfahani AN, Nahrevanian H et al. Concentrations of nitric oxide metabolites in the serum of Iranian multiple sclerosis patients. J Neurol Sci 2010; 294(1-2): 92-4
13. Stewart WC, Giovannoni G, Land JM, McDonald I, Clark JB, Heales Jr. Pretreatment of astrocytes with interferon- -b impairs interferon-g induction of nitric oxide synthase. J Neurochem 1998; 68: 2547-51
14. Okuda Y, Nakatsuji Y, Fujimura H, Esumi H, Ogura T, Yanagihara T et al. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J Neuroimmunol 1995; 62(1): 103-12
15. Garthwaite G, Batchelor AM, Goodwin DA, Hewson AK, Leeming K, Ahmed Z et al. Pathological implications of iNOS expression in central white matter: An ex vivo study of optic nerves from rats with experimental allergic encephalomyelitis. Eur J Neurosci 2005; 21(8): 2127-35
16. Ljubisavljević S, Stojanović I, Pavlović R, Stojnev S, Stevanović I, Sokolović D, Pavlović D. The reduced glutathione and S-nitrosothiols levels in acute phase of experimental demyelinationpathophysiological approach and possible clinical relevancy. Neuroscience 2012; doi.10.1016/j.neuroscience.2012.05.062
17. Johnson AW, Land JM, Thompson EJ, Bolaños JP, Clark JB, Heales SJ. Evidence for increased nitric oxide production in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1995; 58(1): 107
18. Boullerne AI, Rodriguez JJ, Touil T, Brochet B, Schmidt S, Abrous NR, Le Moal M, Pua JR, Jensen MA, Mayo W, Arnason BGW, Petry KG (2002), Anti-S-Nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: Implications for multiple sclerosis. J Neurosci 22 (1): 123-132
19. Stewart WC, Land JM, Clark JB, Heales Jr. Pretreatment of astrocytes with interferon-b prevents neuronal mitochondrial respiratory chain damage. J Neurochem 1997; 70: 432-4
20. Stojanović I, Vojinović S, Ljubisavljević S, Pavlović R, Basić J, Pavlović D, Ilić A, Cvetković T, Stukalov M. IFNb1b therapy modulates L-arginine and nitric oxide metabolism in patients with relapse remittens multiple sclerosis. (in press).
21. Miller E, Walczak A, Saluk J, Ponczek MB, Majsterek I. Oxidative modification of patient's plasma proteins and its role in pathogenesis of multiple sclerosis. Clin Biochem 2011; 45 (1-2): 26-30
22. Foster MW, McMahon TJ, Stamler JS. S-nitrosylation in health and disease. Trends Mol Med 2003; 9: 160-68
23. Drel VR, Lupachyk S, Shevalye H, Vareniuk I, Xu W, Zhang J et al. New Therapeutic and Biomarker Discovery for Peripheral Diabetic Neuropathy: PARP Inhibitor, Nitro tyrosine, and Tumor Necrosis Factor-a. Endocrinology 2010; 151(6): 2547-55
24. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006; 443: 787-95
25. Lipton SA. Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond. Nat Rev Drug Discov 2006; 5: 160-70
26. Cassina P, Peluffo H, Pehar M, Martinez-Palma L, Ressia A, Beckman J et al. Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis. J Neurosci Res 2002; 67: 21-9
27. Estevez AG, Spear N, Manuel SM, Radi R, Henderson CE, Barieto et al. Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J Neurosci 1998; 18(3): 923-31
28. Zhang K, Kaufman RJ. The unfolded protein response: A stress signaling pathway critical for health and disease. Neurology 2006; 66: S102-9
29. Muchowski PJ, Wacker JL. Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 2005; 6:11-22
30. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001; 292: 1552-5
31. Barsoum MJ, Yuan H, Gerencser AA, Liot G, Kushnareva Y, Graber S et al. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 2006; 25: 3900-11
32. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z et al. S-Nitrosylation of Drp1 mediates beta-amyloidrelated mitochondrial fission and neuronal injury. Science 2009; 324: 102-5
33. Bolaños JP, Heales SJR, Land JM, Clark JB. Effect of peroxynitrite on the mitochondrial respiratory chain: Differential susceptibility of neurones and astrocytes in primary cultures. J Neurochem 1995; 64: 1965-72
34. Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shino bu LA, Galasko D et al. Mutations in mitochondrial cyto chro me c oxidase genes segregate with late-onset Alzhe imer disease. Proc. Natl Acad. Sci. USA 1997; 94: 4526-31
35. Haas J, Storch-Hagenlocher B, Biessmann A, Wildemann B. Inducible nitric oxide synthase and argininosuccinate synthetase: Co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with bamyloid 1-42 in vitro. Neurosci Lett 2002; 322: 121-5
36. Akama KT, Van Eldik LJ. b-Amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin- 1b and tumor necrosis factor-a (TNFa)-dependent, and involves a TNF-a receptor-associated factor- and NF-kBinducing kinase-dependent signaling mechanism. J Biol Chem 2000; 275: 7918-24
37. Keil U, Bonert A, Marques CA, Scherping I, Weyermann J, Strosznajder JB et al. Amyloid b-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J Biol Chem 2004; 279: 310-20
38. Sultana R, Perluigi M, Butterfield DA. Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: Insights into mechanism of neurodegeneration from redox proteomics. Antioxid Redox Signal 2006; 8(11-12): 2021-37
39. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature 2004;430: 631-9
40. Foster MW, Hess DT, Stamler JS. Protein S-nitrosylation in health and disease: A current perspective. Trends Mol Med 2009; 15: 391-404
41. Liu L, Yan Y, Zeng M, Zhang J, Hanes MA, Ahearn G et al. Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell 2004; 116: 617-28
42. Ljubisavljević S, Stojanović I, Pavlović D, Sokolović D, Stevanović I. Aminoguanidine and N-Acetyl-Cysteine sup presses oxidative and nitrosative stress in EAE rat brains. Redox Rep 2011; 16 (4): 166-72
43. Gu Z, Nakamura T, Lipton SA. Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol Neurobiol 2010; 41: 55-72
44. Chung KK, Thomas B, Li X, Pletnikova O, Troncoso JC, Marsh L, Dawson VL, Dawson TM. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 2004; 304, 1328-31
45. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C et al. Blockade of microglial activation is neuroprotective in the L-methyl-4-phe- nyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci 2002; 22: 1763-71
46. Iravani MM, Kashefi K, Mander P, Rose S, Jenner P. Involvement of inducible nitric oxide synthase in inflammation- induced dopaminergic neurodegeneration. Neuroscience 2002; 110, 49- 58
47. Gao HM, Liu B, Zhang W, Hong JS. Synergistic dopaminergic neurotoxicity of MPTP and inflammagen lipopolysaccharide: Relevance to the etiology of Parkinson's disease. FASEB J. 2003; 17, 1957-59
48. Goldberg D, Soleas G. Wine and health: A paradigm for alcohol and antioxidants, Journal of Medical Bio chemistry 2011; 30: 93-102
49. Hübner-Woźniak E, Okecka-Szymańska J, Stupnicki R, Malara M, Kozdroń E. Age-Related blood antioxidant capacity in men and women. Journal of Medical Biochemistry 2011; 30: 103-8
50. Muchowski PJ, Wacker JL. Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 2005; 6: 11-22
51. Dou F, Netzer WJ, Tanemura K. Chaperones increase association of tau protein with microtubules. Proc Natl Acad Sci USA 2003; 100: 721-6
52. Martinez-Ruiz A, Villanueva L, Gonzalez de Orduna C. Snitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. Proc Natl Acad Sci USA 2005; 102: 8525-30